CrohnB.B., RosenbergH.The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am J Med Sci.1925; 170: 220–228.
4.
Lennard-JonesJ.E., MelvilleD.M., MorsonB.C.Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut.1990; 31: 800–806.
5.
RansohoffD.F., RiddellR.H., LevinB.Ulcerative colitis and colonic cancer: problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum.1985; 28: 383–388.
6.
MathenyR., SymmondsR.E.Jr. The incidence of colon carcinoma complicating ulcerative colitis. Surg Clin North Am.1986; 66: 801–806.
ArvanitisM.L., JagelmanD.G., FazioV.W.Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum.1990; 33: 639–642.
9.
GardnerE.J., RichardsR.C.Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet.1953; 5: 139–147.
10.
BodmerW.F., BaileyC.J., BodmerJ.Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature.1987; 328: 614–616.
11.
LynchH.T., KimberlingW., AlbanoW.A.Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer.1985; 56: 934–938.
12.
WolberR.A., OwenD.A.Flat adenomas of the colon. Hum Pathol.1991; 22: 70–74.
13.
MutoT., KamiyaJ., SawadaT.Small “flat adenoma” of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum.1985; 28: 847–851.
14.
YaoT., TadaS., TsuneyoshiM.Colorectal counterpart of gastric depressed adenoma: a comparison with flat and polypoid adenomas with special reference to the development of pericryptal fibroblasts. Am J Surg Pathol.1994; 18: 559–568.
15.
WadaR., MatsukumaS., AbeH.Histopathological studies of superficial-type early colorectal carcinoma. Cancer.1996; 77: 44–50.
16.
BirdR.P.Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett.1987; 37: 147–151.
17.
PretlowT.P., BarrowB.J., AshtonW.S.Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res.1991; 51: 1564–1567.
18.
RoncucciL., StampD., MedlineA.Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol.1991; 22: 287–294.
19.
StoperaS.A., BirdR.P.Expression of ras oncogene mRNA and protein in aberrant crypt foci. Carcinogenesis.1992; 13: 1863–1868.
20.
JenJ., PowellS.M., PapadopoulosN.Molecular determinants of dysplasia in colorectal lesions. Cancer Res.1994; 54: 5523–5526.
21.
YamashitaN., MinamotoT., OchiaiA.Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology.1995; 108: 434–440.
22.
KonishiF., MorsonB.C.Pathology of colorectal adenoma: a colonoscopic survey. J Clin Pathol.1982; 35: 830–841.
23.
MarsonB.C., SobinL.H.Histological typing of intestinal tumors. International Histological Classification of Tumours. Vol 15. Geneva: World Health Organization; 1976.
24.
CooperH.S.Surgical pathology of endoscopically removed malignant polyps of the colon and rectum. Am J Surg Pathol.1983; 7: 613–623.
25.
HaggittR.C., GlotzbachR.E., SofferE.E.Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology.1985; 89: 328–336.
26.
NivatvongsS., RojanasakulA., ReimanHM. The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma. Dis Colon Rectum.1991; 34: 323–328.
27.
FreiJ.V.Endoscopic large bowel polypectomy: adequate treatment of some completely removed, minimally invasive lesions. Am J Surg Pathol.1985; 9: 355–35.
28.
LongacreT.A., Fenoglio-PreiserC.M.Mixed hyperplastic adenomatouspolyps/serrated adenomas: a distinct form of colorectal neoplasia. Am J Surg Pathol.1990; 14: 524–537.
29.
GoldmanH., MingS., HickockD.F.Nature and significance of hyperplastic polyps of the human colon. Arch Pathol.1970; 89: 349–354.
30.
VogelsteinB., FearonE.R., HamiltonS.R.Genetic alterations during colorectal-tumor development. N Engl J Med.1988; 319: 525–532.
31.
KinzlerK.W., NilbertM.C., SuL.K.Identification of FAP locus genes from chromosome 5q21. Science.1991; 253: 661–665.
32.
PowellS.M., ZilzN., Beazer-BarclayY.APC mutations occur early during colorectal tumorigenesis. Nature.1992; 359: 235–237.
33.
JessupJ.M.Molecular biology of neoplastic transformation of the large bowel. Surg Oncol Clin North Am.1994; 3: 449–477.
34.
SasakiM., SugioK., SasazukiT.K-ras activation in colorectal tumors from patients with familial polyposis coli. Cancer.1990; 65: 2576–2579.
35.
SalhabN., JonesD.J., BosJ.L.Detection of ras gene alterations and ras proteins in colorectal cancer. Dis Colon Rectum.1989; 32: 659–664.
36.
ChoK.R., OlinerJ.D., SimonsJ.W.The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics.1994; 19: 525–531.
37.
FearonE.R., ChoK.R., NigroJ.M.Identification of a chromosome 18q gene that is altered in colorectal cancers. Science.1990; 247: 49–56.
38.
CulottaE., KoshlandD.E.Jr. DNA repair works its works its way to the top. Science.1994; 266: 1926–1929.
39.
ForgacsI.Oncogenes and gastrointestinal cancer. Gut.1988; 29: 417–421.
40.
BolenJ.B., VeilletteA., SchwartzA.M.Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci U S A.1987; 84: 2251–2255.
41.
MeltzerS.J., AhnenD.J., BattiforaH.Protooncogene abnormalities in colon cancers and adenomatous polyps. Gastroenterology.1987; 92: 1174–1180.
42.
TalM., WetzlerM., JosefbergZ.Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res.1988; 48: 1517–1520.
43.
Martin-ZancaD., HughesS.H., BarbacidM.A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature.1986; 319: 743–748.
44.
FriedmanE., UrmacherC., WinawerS.A model for human colon carcinoma evolution based on the differential response of cultured preneoplastic, premalignant and malignant cells to 12-O-tetradecanoylphorbol-13-acetate. Cancer Res.1984; 44: 1568–1578.
45.
MaciewiczR.A., WardaleR.J., EtheringtonD.J.Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Int J Cancer.1989; 43: 478–486.
46.
ForsterS.J., TalbotI.C., ClaytonD.G.Tumour basement membrane laminin in adenocarcinoma of rectum: an immunohistochemical study of biological and clinical significance. Int J Cancer.1986; 37: 813–817.
47.
FriedmanE., VerderameM., WinawerS.Actin cytoskeletal organization loss in the benign-to-malignant tumor transition in cultured human colonic epithelial cells. Cancer Res.1984; 44: 3040–3050.
48.
CiclitiraP.J., MacartneyJ.C., EvanG.Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders. J Pathol.1987; 151: 293–296.
49.
MullerR., SlamonD.J., AdamsonE.D.Transcription of c-onc genes c-ras Ki and c-fms during mouse development. Mol Cell Biol.1983; 3: 1062–1069.
50.
MoriS., AkiyamaT., YamadaY.C-erb B-2 gene product, a membrane protein commonly expressed on human fetal epithelial cells. Lab Invest.1989; 61: 93–97.
51.
HiraiS.I., RyseckR.P., MechtaF.Characterization of junD: a new member of the jun proto-oncogene family. EMBO J.1989; 8: 1433–1439.